🇺🇸 FDA
Patent

US 8058280

Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof

granted A61KA61K31/519A61P

Quick answer

US patent 8058280 (Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof) held by Takeda Pharmaceutical Company Limited expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/519, A61P, A61P1/00, A61P1/04